Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure

Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them...

Full description

Saved in:

Bibliographic Details
Published in:	Insights into imaging Vol. 16; no. 1; pp. 47 - 10
Main Authors:	Martí-Bonmatí, Luis, Blanquer, Ignacio, Tsiknakis, Manolis, Tsakou, Gianna, Martinez, Ricard, Capella-Gutierrez, Salvador, Zullino, Sara, Meszaros, Janos, Bron, Esther E., Gelpi, Jose Luis, Riklund, Katrine, Chaabane, Linda, Schlemmer, Heinz-Peter, Aznar, Mario, Serrano Candelas, Patricia, Gordebeke, Peter, Hierath, Monika
Format:	Journal Article
Language:	English
Published:	Vienna Springer Vienna 24.02.2025 Springer Nature B.V SpringerOpen
Subjects:	Algorithms Annotations Artificial intelligence Cancer Cancer research Datasets Diagnostic Radiology Empowerment European Health Data Space Fragmentation Heterogeneity Imaging Infrastructure Internal Medicine Interoperability Interventional Radiology Medical imaging Medical research Medicine Medicine & Public Health Neuroradiology Pathology Privacy Quality standards Radiology Repositories Statement Ultrasound Europe Infrastructure Cancer research European Health Data Space Artificial intelligence Imaging
ISSN:	1869-4101, 1869-4101
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe’s Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. Critical relevance statement EUCAIM’s federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. Key Points AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM’s federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data.
AbstractList	Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe's Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. CRITICAL RELEVANCE STATEMENT: EUCAIM's federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. KEY POINTS: AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM's federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data.Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe's Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. CRITICAL RELEVANCE STATEMENT: EUCAIM's federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. KEY POINTS: AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM's federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data. Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe's Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. CRITICAL RELEVANCE STATEMENT: EUCAIM's federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. KEY POINTS: AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM's federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data. Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe’s Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. Critical relevance statement: EUCAIM’s federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. Key Points: AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM’s federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data. Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe’s Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data.The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing.Critical relevance statementEUCAIM’s federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators.Key PointsAI solutions to advance cancer care rely on large, high-quality real-world datasets.EUCAIM’s federated infrastructure for cancer image data empowers cancer research in Europe.It provides access to research tools, images, and related clinical, pathology and molecular data. Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe’s Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. Critical relevance statement EUCAIM’s federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. Key Points AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM’s federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data. Abstract Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe’s Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing. Critical relevance statement EUCAIM’s federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators. Key Points AI solutions to advance cancer care rely on large, high-quality real-world datasets. EUCAIM’s federated infrastructure for cancer image data empowers cancer research in Europe. It provides access to research tools, images, and related clinical, pathology and molecular data.
ArticleNumber	47
Author	Schlemmer, Heinz-Peter Capella-Gutierrez, Salvador Tsiknakis, Manolis Hierath, Monika Bron, Esther E. Gordebeke, Peter Martí-Bonmatí, Luis Serrano Candelas, Patricia Meszaros, Janos Blanquer, Ignacio Riklund, Katrine Martinez, Ricard Chaabane, Linda Aznar, Mario Tsakou, Gianna Gelpi, Jose Luis Zullino, Sara
Author_xml	– sequence: 1 givenname: Luis orcidid: 0000-0002-8234-010X surname: Martí-Bonmatí fullname: Martí-Bonmatí, Luis email: luis_marti@iislafe.es organization: Biomedical Imaging Research Group, Instituto de Investigación Sanitaria La Fe – sequence: 2 givenname: Ignacio surname: Blanquer fullname: Blanquer, Ignacio organization: Universitat Politècnica de València – sequence: 3 givenname: Manolis surname: Tsiknakis fullname: Tsiknakis, Manolis organization: Foundation for Research and Technology, Hellas – sequence: 4 givenname: Gianna surname: Tsakou fullname: Tsakou, Gianna organization: Maggioli SPA, Research and Development Lab – sequence: 5 givenname: Ricard surname: Martinez fullname: Martinez, Ricard organization: Universitat de València – sequence: 6 givenname: Salvador surname: Capella-Gutierrez fullname: Capella-Gutierrez, Salvador organization: Barcelona Supercomputing Center – sequence: 7 givenname: Sara surname: Zullino fullname: Zullino, Sara organization: EATRIS ERIC – sequence: 8 givenname: Janos surname: Meszaros fullname: Meszaros, Janos organization: Center for IT and IP Law, KU Leuven – sequence: 9 givenname: Esther E. surname: Bron fullname: Bron, Esther E. organization: Biomedical Imaging Group Rotterdam, Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam – sequence: 10 givenname: Jose Luis surname: Gelpi fullname: Gelpi, Jose Luis organization: Universitat De Barcelona – sequence: 11 givenname: Katrine surname: Riklund fullname: Riklund, Katrine organization: Department of Diagnostics and Interventions, Umea Universitet – sequence: 12 givenname: Linda surname: Chaabane fullname: Chaabane, Linda organization: EURO-BIOIMAGING ERIC, Med-Hub, Institute of Biostructures and Bioimaging (IBB), Italian National Research Council (CNR) – sequence: 13 givenname: Heinz-Peter surname: Schlemmer fullname: Schlemmer, Heinz-Peter organization: Division of Radiology, German Cancer Research Center (DKFZ) – sequence: 14 givenname: Mario surname: Aznar fullname: Aznar, Mario organization: Matical Innovation – sequence: 15 givenname: Patricia surname: Serrano Candelas fullname: Serrano Candelas, Patricia organization: Biomedical Imaging Research Group, Instituto de Investigación Sanitaria La Fe – sequence: 16 givenname: Peter surname: Gordebeke fullname: Gordebeke, Peter organization: EIBIR Gemeinnutzige Gmbh Zur Forderung Der Erforschung Der Biomedizinischen Bildgebung – sequence: 17 givenname: Monika surname: Hierath fullname: Hierath, Monika organization: EIBIR Gemeinnutzige Gmbh Zur Forderung Der Erforschung Der Biomedizinischen Bildgebung
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/39992532$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-237322$$DView record from Swedish Publication Index (Umeå universitet)
BookMark	eNp9ksFv0zAUxi00xLayf4ADisRll8CznTgJF1SVApUGXBhXy3GeW1dpXOyEbf89btONdYf5Ysvv93367PfOyUnnOiTkDYX3lJbiQ6CcZVkKLE-BVpSnty_IWSxUaUaBnjw6n5KLENYQF-eUl_wVOeVVVbGcszPyY77Zuhv0tlsmWnUafeIxoPJ6ldgumQ_ebfFj0q8wmV_Ppovv95TdqOVOZDvjVej9oPvB42vy0qg24MVhn5DrL_Nfs2_p1c-vi9n0KtV5SfsUdcMa4JXQmclULcosh8Jgw3gtAPPKNLXQpqGUA2SmKDIOTNSi0dzoCnLkE7IYfRun1nLrYxp_J52ycn_h_FIq31vdoqy5hoqC0SXyrKjqslYIIJqcGdCM6-iVjl7hBrdDfeT22f6e7t2GzSAZLzhjkf808hHeYKOx671qj2THlc6u5NL9lbFvOQgB0eHy4ODdnwFDLzc2aGxb1aEbguS0AFaULDZsQt49Qddu8F382z1VZIJBEam3jyM9ZLnvcwTYCGjvQvBoHhAKu1xCjvMk4zzJ_TzJ2ygqn4i07VVv3e5Ztn1eyg9_ut2NFvr_sZ9R_QO5RN8W
CitedBy_id	crossref_primary_10_1016_j_rxeng_2025_501726 crossref_primary_10_1007_s00330_025_11708_9 crossref_primary_10_1016_j_ejrad_2025_112327 crossref_primary_10_1016_j_rx_2025_501726
Cites_doi	10.15497/RDA00078 10.1001/jamanetworkopen.2020.0265 10.1038/s41591-018-0320-3 10.1186/s12910-022-00848-y 10.1007/s13347-018-0320-8 10.1038/s42256-020-0186-1 10.1038/sdata.2016.18 10.3389/frai.2023.1020592 10.1108/JICA-11-2021-0059 10.1038/s41746-019-0158-1 10.1016/j.compbiomed.2023.106848 10.1186/s41747-022-00281-1 10.1038/s41746-020-00323-1 10.1016/j.celrep.2018.03.086 10.5281/zenodo.10777926 10.1038/s41597-019-0184-5 10.1056/NEJMp1714229 10.1038/s43856-022-00199-0 10.1038/s41437-020-0303-2 10.1038/d41586-019-01715-4
ContentType	Journal Article
Contributor	Di Leo, Giovanni Pedraza, Salvador Barbieri, Laurent Langs, Georg Blázquez, Javier Rückert, Daniel Hedlund, Joel Gazinska, Patrycja García, Oscar Gil Castelo-Branco, Miguel França, Manuela Alberich-Bayarri, Angel Haybaeck, Johannes Beets-Tan, Regina Rosell Tejada, José Miguel van Ginneken, Bram Neri, Emanuele Hernandez-Ferrer, Carles Pallocca, Matteo Sala, Evis Jaulent, Marie-Christine López-Rueda, Antonio Roussakis, Yiannis Heese, Harald Persson, Bengt Holub, Petr Strand, Fredrik D'Ascenzo, Nicola Aiello, Marco Saint-Aubert, Laure Seebohm, Annabel Papanikolaou, Nikolaos Sousa Pinto, Cátia Dudova, Zdenka Leisz, Hanna Van den Bulcke, Marc Sandberg, Nils Martin-Sanchez, Fernando Bobowicz, Maciej Fournier, Laure Chouvarda, Ioanna Catalano, Carlo Marx, Gernot Rodríguez González, David Lambin, Philippe Scollen, Serena Penzkofer, Tobias Huys, Isabelle Humbert, Olivier Fuhrmann, Patrick Beregi, Jean-Paul Marsoni, Silvia Navarro, Arcadi Parra Calderón, Carlos Luis Figueiras Gómez, Sergio Sáez-Domingo, Daniel Vos, Wim EUCAIM Consortium European Society of Radiology
Contributor_xml	– sequence: 1 givenname: Hanna surname: Leisz fullname: Leisz, Hanna – sequence: 1 surname: EUCAIM Consortium European Society of Radiology fullname: EUCAIM Consortium European Society of Radiology – sequence: 2 givenname: Nicola surname: D'Ascenzo fullname: D'Ascenzo, Nicola – sequence: 3 givenname: Miguel surname: Castelo-Branco fullname: Castelo-Branco, Miguel – sequence: 4 givenname: Ioanna surname: Chouvarda fullname: Chouvarda, Ioanna – sequence: 5 givenname: Laure surname: Fournier fullname: Fournier, Laure – sequence: 6 givenname: Sergio surname: Figueiras Gómez fullname: Figueiras Gómez, Sergio – sequence: 7 givenname: Arcadi surname: Navarro fullname: Navarro, Arcadi – sequence: 8 givenname: Nikolaos surname: Papanikolaou fullname: Papanikolaou, Nikolaos – sequence: 9 givenname: Laurent surname: Barbieri fullname: Barbieri, Laurent – sequence: 10 givenname: Jean-Paul surname: Beregi fullname: Beregi, Jean-Paul – sequence: 11 givenname: Georg surname: Langs fullname: Langs, Georg – sequence: 12 givenname: David surname: Rodríguez González fullname: Rodríguez González, David – sequence: 13 givenname: Evis surname: Sala fullname: Sala, Evis – sequence: 14 givenname: Yiannis surname: Roussakis fullname: Roussakis, Yiannis – sequence: 15 givenname: Giovanni surname: Di Leo fullname: Di Leo, Giovanni – sequence: 16 givenname: Antonio surname: López-Rueda fullname: López-Rueda, Antonio – sequence: 17 givenname: Salvador surname: Pedraza fullname: Pedraza, Salvador – sequence: 18 givenname: Javier surname: Blázquez fullname: Blázquez, Javier – sequence: 19 givenname: Carlos Luis surname: Parra Calderón fullname: Parra Calderón, Carlos Luis – sequence: 20 givenname: Silvia surname: Marsoni fullname: Marsoni, Silvia – sequence: 21 givenname: Daniel surname: Sáez-Domingo fullname: Sáez-Domingo, Daniel – sequence: 22 givenname: Marco surname: Aiello fullname: Aiello, Marco – sequence: 23 givenname: Fredrik surname: Strand fullname: Strand, Fredrik – sequence: 24 givenname: Marie-Christine surname: Jaulent fullname: Jaulent, Marie-Christine – sequence: 25 givenname: Joel surname: Hedlund fullname: Hedlund, Joel – sequence: 26 givenname: Laure surname: Saint-Aubert fullname: Saint-Aubert, Laure – sequence: 27 givenname: Carlo surname: Catalano fullname: Catalano, Carlo – sequence: 28 givenname: Regina surname: Beets-Tan fullname: Beets-Tan, Regina – sequence: 29 givenname: Harald surname: Heese fullname: Heese, Harald – sequence: 30 givenname: Angel surname: Alberich-Bayarri fullname: Alberich-Bayarri, Angel – sequence: 31 givenname: Bram surname: van Ginneken fullname: van Ginneken, Bram – sequence: 32 givenname: Marc surname: Van den Bulcke fullname: Van den Bulcke, Marc – sequence: 33 givenname: Daniel surname: Rückert fullname: Rückert, Daniel – sequence: 34 givenname: Emanuele surname: Neri fullname: Neri, Emanuele – sequence: 35 givenname: Philippe surname: Lambin fullname: Lambin, Philippe – sequence: 36 givenname: Gernot surname: Marx fullname: Marx, Gernot – sequence: 37 givenname: Bengt surname: Persson fullname: Persson, Bengt – sequence: 38 givenname: Wim surname: Vos fullname: Vos, Wim – sequence: 39 givenname: Cátia surname: Sousa Pinto fullname: Sousa Pinto, Cátia – sequence: 40 givenname: Patrick surname: Fuhrmann fullname: Fuhrmann, Patrick – sequence: 41 givenname: Maciej surname: Bobowicz fullname: Bobowicz, Maciej – sequence: 42 givenname: Carles surname: Hernandez-Ferrer fullname: Hernandez-Ferrer, Carles – sequence: 43 givenname: Olivier surname: Humbert fullname: Humbert, Olivier – sequence: 44 givenname: José Miguel surname: Rosell Tejada fullname: Rosell Tejada, José Miguel – sequence: 45 givenname: Manuela surname: França fullname: França, Manuela – sequence: 46 givenname: Petr surname: Holub fullname: Holub, Petr – sequence: 47 givenname: Zdenka surname: Dudova fullname: Dudova, Zdenka – sequence: 48 givenname: Isabelle surname: Huys fullname: Huys, Isabelle – sequence: 49 givenname: Matteo surname: Pallocca fullname: Pallocca, Matteo – sequence: 50 givenname: Johannes surname: Haybaeck fullname: Haybaeck, Johannes – sequence: 51 givenname: Patrycja surname: Gazinska fullname: Gazinska, Patrycja – sequence: 52 givenname: Annabel surname: Seebohm fullname: Seebohm, Annabel – sequence: 53 givenname: Tobias surname: Penzkofer fullname: Penzkofer, Tobias – sequence: 54 givenname: Nils surname: Sandberg fullname: Sandberg, Nils – sequence: 55 givenname: Oscar Gil surname: García fullname: García, Oscar Gil – sequence: 56 givenname: Fernando surname: Martin-Sanchez fullname: Martin-Sanchez, Fernando – sequence: 57 givenname: Serena surname: Scollen fullname: Scollen, Serena
Copyright	The Author(s) 2025 2025. The Author(s). Copyright Springer Nature B.V. Dec 2025 The Author(s) 2025 2025
Copyright_xml	– notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Springer Nature B.V. Dec 2025 – notice: The Author(s) 2025 2025
CorporateAuthor	the EUCAIM Consortium European Society of Radiology EUCAIM Consortium
CorporateAuthor_xml	– name: the EUCAIM Consortium – name: European Society of Radiology – name: EUCAIM Consortium
DBID	C6C AAYXX CITATION NPM 3V. 7RV 7X7 7XB 8AO 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. KB0 M0S NAPCQ P5Z P62 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM ADHXS ADTPV AOWAS D8T D93 ZZAVC DOA
DOI	10.1186/s13244-025-01913-x
DatabaseName	Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials - QC ProQuest Central ProQuest Technology Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Umeå universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Umeå universitet SwePub Articles full text DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef PubMed Publicly Available Content Database Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) Advanced Technologies & Aerospace Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic PubMed Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7RV name: ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. url: https://search.proquest.com/nahs sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1869-4101
EndPage	10
ExternalDocumentID	oai_doaj_org_article_b3c0910fc8e3479b8bae006d52f0c23c oai_DiVA_org_umu_237322 PMC11850660 39992532 10_1186_s13244_025_01913_x
Genre	Journal Article
GeographicLocations	Europe
GeographicLocations_xml	– name: Europe
GrantInformation_xml	– fundername: European Commission funderid: http://dx.doi.org/10.13039/501100000780
GroupedDBID	-A0 0R~ 2JY 3V. 40G 53G 5VS 67Z 7RV 7X7 8AO 8FE 8FG 8FI 8FJ AAFWJ AAJSJ AAKKN ABDBF ABEEZ ABUWG ACACY ACGFS ACIHN ACUHS ACULB ADBBV ADINQ AEAQA AFGXO AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ARAPS BAPOH BAWUL BCNDV BENPR BGLVJ BKEYQ BPHCQ BVXVI C24 C6C CCPQU DIK EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE KQ8 M~E NAPCQ O9I OK1 P62 PIMPY PQQKQ PROAC QOS R9I RNS RPM RSV S1Z S27 SMD SOJ T13 TUS U2A UKHRP WK8 AASML AAYXX AFFHD CITATION M48 PHGZM PHGZT PPXIY PQGLB NPM 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PQEST PQUKI PRINS 7X8 5PM 2VQ 4.4 ABFSG ACSTC ADHXS ADRAZ ADTPV AEZWR AFHIU AHSBF AHWEU AIXLP AOWAS D8T D93 EJD EN4 H13 HF~ HZ~ IPNFZ O9- RIG ZZAVC
ID	FETCH-LOGICAL-c581t-ecd2d0396c4f4ab684507fed23b60e59fdb6cfd113004f7743026b6dc3fc905e3
IEDL.DBID	C24
ISICitedReferencesCount	5
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001429208900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1869-4101
IngestDate	Fri Oct 03 12:32:32 EDT 2025 Tue Nov 04 16:45:43 EST 2025 Tue Nov 04 02:05:33 EST 2025 Sun Nov 09 12:33:42 EST 2025 Tue Oct 14 14:11:03 EDT 2025 Thu Apr 03 07:05:21 EDT 2025 Sat Nov 29 08:19:27 EST 2025 Tue Nov 18 21:01:49 EST 2025 Tue Feb 25 01:11:39 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Infrastructure Cancer research European Health Data Space Artificial intelligence Imaging
Language	English
License	2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c581t-ecd2d0396c4f4ab684507fed23b60e59fdb6cfd113004f7743026b6dc3fc905e3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-8234-010X
OpenAccessLink	https://link.springer.com/10.1186/s13244-025-01913-x
PMID	39992532
PQID	3170746207
PQPubID	2034747
PageCount	10
ParticipantIDs	doaj_primary_oai_doaj_org_article_b3c0910fc8e3479b8bae006d52f0c23c swepub_primary_oai_DiVA_org_umu_237322 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11850660 proquest_miscellaneous_3170278203 proquest_journals_3170746207 pubmed_primary_39992532 crossref_primary_10_1186_s13244_025_01913_x crossref_citationtrail_10_1186_s13244_025_01913_x springer_journals_10_1186_s13244_025_01913_x
PublicationCentury	2000
PublicationDate	2025-02-24
PublicationDateYYYYMMDD	2025-02-24
PublicationDate_xml	– month: 02 year: 2025 text: 2025-02-24 day: 24
PublicationDecade	2020
PublicationPlace	Vienna
PublicationPlace_xml	– name: Vienna – name: Germany – name: Heidelberg
PublicationTitle	Insights into imaging
PublicationTitleAbbrev	Insights Imaging
PublicationTitleAlternate	Insights Imaging
PublicationYear	2025
Publisher	Springer Vienna Springer Nature B.V SpringerOpen
Publisher_xml	– name: Springer Vienna – name: Springer Nature B.V – name: SpringerOpen
References	1913_CR9 GA Kaissis (1913_CR16) 2020; 2 M Lehne (1913_CR6) 2019; 2 1913_CR19 1913_CR18 MD Wilkinson (1913_CR17) 2016; 3 1913_CR15 J Saltz (1913_CR20) 2018; 23 1913_CR14 1913_CR13 1913_CR12 1913_CR11 1913_CR10 A Blasimme (1913_CR23) 2018; 31 T Schaffter (1913_CR2) 2020; 3 HH Pierce (1913_CR26) 2019; 570 1913_CR1 R Agrawal (1913_CR33) 2020; 124 1913_CR3 MD Wilkinson (1913_CR7) 2019; 6 DS Char (1913_CR25) 2018; 378 1913_CR29 1913_CR28 1913_CR27 N Khalid (1913_CR31) 2023; 158 J Piasecki (1913_CR24) 2022; 23 1913_CR22 1913_CR21 S Genovese (1913_CR5) 2022; 30 H Kondylakis (1913_CR8) 2022; 6 N Rieke (1913_CR30) 2020; 3 D-M Koh (1913_CR32) 2022; 2 B Norgeot (1913_CR4) 2019; 25
References_xml	– ident: 1913_CR29 doi: 10.15497/RDA00078 – volume: 3 start-page: e200265 year: 2020 ident: 1913_CR2 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2020.0265 – volume: 25 start-page: 14 year: 2019 ident: 1913_CR4 publication-title: Nat Med doi: 10.1038/s41591-018-0320-3 – ident: 1913_CR14 – volume: 23 year: 2022 ident: 1913_CR24 publication-title: BMC Med Ethics doi: 10.1186/s12910-022-00848-y – volume: 31 start-page: 473 year: 2018 ident: 1913_CR23 publication-title: Philos Technol doi: 10.1007/s13347-018-0320-8 – ident: 1913_CR18 – ident: 1913_CR22 – volume: 2 start-page: 305 year: 2020 ident: 1913_CR16 publication-title: Nat Mach Intell doi: 10.1038/s42256-020-0186-1 – volume: 3 year: 2016 ident: 1913_CR17 publication-title: Sci Data doi: 10.1038/sdata.2016.18 – ident: 1913_CR19 doi: 10.3389/frai.2023.1020592 – ident: 1913_CR28 – volume: 30 start-page: 363 year: 2022 ident: 1913_CR5 publication-title: J Integr Care doi: 10.1108/JICA-11-2021-0059 – ident: 1913_CR9 – ident: 1913_CR12 – volume: 2 start-page: 79 year: 2019 ident: 1913_CR6 publication-title: NPJ Digit Med doi: 10.1038/s41746-019-0158-1 – ident: 1913_CR10 – volume: 158 start-page: 106848 year: 2023 ident: 1913_CR31 publication-title: Comput Biol Med doi: 10.1016/j.compbiomed.2023.106848 – ident: 1913_CR1 – volume: 6 start-page: 29 year: 2022 ident: 1913_CR8 publication-title: Eur Radiol Exp doi: 10.1186/s41747-022-00281-1 – volume: 3 start-page: 119 year: 2020 ident: 1913_CR30 publication-title: NPJ Digit Med doi: 10.1038/s41746-020-00323-1 – ident: 1913_CR3 – ident: 1913_CR13 – ident: 1913_CR15 – volume: 23 start-page: 181 year: 2018 ident: 1913_CR20 publication-title: Cell Rep doi: 10.1016/j.celrep.2018.03.086 – ident: 1913_CR21 doi: 10.5281/zenodo.10777926 – volume: 6 year: 2019 ident: 1913_CR7 publication-title: Sci Data doi: 10.1038/s41597-019-0184-5 – volume: 378 start-page: 981 year: 2018 ident: 1913_CR25 publication-title: N Engl J Med doi: 10.1056/NEJMp1714229 – ident: 1913_CR27 – volume: 2 start-page: 133 year: 2022 ident: 1913_CR32 publication-title: Commun Med doi: 10.1038/s43856-022-00199-0 – volume: 124 start-page: 525 year: 2020 ident: 1913_CR33 publication-title: Heredity (Edinb) doi: 10.1038/s41437-020-0303-2 – ident: 1913_CR11 – volume: 570 start-page: 30 year: 2019 ident: 1913_CR26 publication-title: Nature doi: 10.1038/d41586-019-01715-4
SSID	ssj0000331383
Score	2.3607447
Snippet	Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new... Abstract Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the...
SourceID	doaj swepub pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	47
SubjectTerms	Algorithms Annotations Artificial intelligence Cancer Cancer research Datasets Diagnostic Radiology Empowerment European Health Data Space Fragmentation Heterogeneity Imaging Infrastructure Internal Medicine Interoperability Interventional Radiology Medical imaging Medical research Medicine Medicine & Public Health Neuroradiology Pathology Privacy Quality standards Radiology Repositories Statement Ultrasound
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hCiEuiJZXaEFBQlzAamLnZW5LuxUcuuJAUW-Wn2qkblrtdqv-_I7tJDSAyoVjkklij7-Jv4mTbwDeY-wxaXNOKNWa4HzriKqUI5LXpTQu6L2EYhP1YtGcnvLvd0p9-W_CojxwdNy-YtpPaU431v_0qBolLSLFlNRlmjLtn75Zze8kU-EZzFiOudfwl0xT7a8x7SoK4qu3IqvJGbmZzERBsP9vLPPPjyXHFdPf1EXDjHT0FJ70VDKdxS5swwPb7cCj436x_Bks5stLXwMNr5JqP7irtJf2OUvbLo3v4T-nyADT-cnB7NvxYNUuQ-kiNHIrGQVmNyv7HE6O5j8OvpK-fALRZZNfEasNNRnjlS5cIVXVFMj9nDWUqSqzJXdGVdqZ3C9oFQ5pIMN8TFVGM6d5Vlr2Ara6i86-gtQ5qr3SPEY_po9IGpEI1porWVAjcSOBfHCl0L22uC9xcS5CjtFUIrpfoPtFcL-4SeDjeM5lVNa41_qLH6HR0qtihx2IFdFjRfwLKwnsDeMr-lBdCyRQvuYKgiiBd-NhDDK_ciI7e7GJNtQrC7IEXkY4jC1BhsdpyWgCzQQok6ZOj3TtWRDyxr6WSPmyBD4NmPrVrvt88SHibnKLw_bnLHhjs9wIymocq9f_w2m78JiGqKGEFnuwhaizb-Chvr5q16u3IexuAVnVLv0 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB5BQaiX8m4NBRkJcYFV7V0_uaBQUsGhEQeKclt5X60l4qROU_XnM7teuzKgXDgmnii7npndb3bs7wN4i7nHKh2XhFIpCe63hohMGFKVeVop4_henNhEPpsV83n53R-4rf1jlf2a6BZqtZT2jPwI9zkrjUGj_NPqkljVKNtd9RIad-Gelc22cZ7P8-GMJWIsxgqsf1emyI7WWHwlCbEarohtYkZuRvuRo-3_F9b8-5HJoW_6B8eo25dOHv7vjB7Bnkek4aQLocdwRzdP4MGp77k_hdl0sbJSajiMUNoYaUPPEHQR1k3YHed_DBFIhtOz48m3096qXjgFJDQybdXx1G5a_QzOTqY_jr8Sr8JAZFrEV0RLRVXEykwmJqlEViQIIY1WlIks0mlplMikUbHtiyUG0STDsk5kSjIjyyjV7DnsNMtGH0BoDJWWsB4XEaxCEXsinsxlKaqEqgo_BBD3vuDSU5RbpYxf3JUqRcY7_3H0H3f-4zcBvB9-s-oIOrZaf7YuHiwtubb7Ytmec5-rXDBpUZSRhbbv2YpCVBoXJ5VSE-H4ZQCHvUO5z_g1v_VmAG-Gy5irtgFTNXq56WyoJShkAex38TSMBIFiSVNGAyhGkTYa6vhKU184PnCca4rIMQrgQx-Ut-Padi_edYE7-osv9c-JuxubxYZTlqOvXmyf70vYpS6hKKHJIexgPOlXcF9eX9Xr9rXLyN-hbDyR priority: 102 providerName: ProQuest
Title	Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure
URI	https://link.springer.com/article/10.1186/s13244-025-01913-x https://www.ncbi.nlm.nih.gov/pubmed/39992532 https://www.proquest.com/docview/3170746207 https://www.proquest.com/docview/3170278203 https://pubmed.ncbi.nlm.nih.gov/PMC11850660 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-237322 https://doaj.org/article/b3c0910fc8e3479b8bae006d52f0c23c
Volume	16
WOSCitedRecordID	wos001429208900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: P5Z dateStart: 20250101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: 7X7 dateStart: 20250101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: BENPR dateStart: 20250101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: 7RV dateStart: 20250101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: PIMPY dateStart: 20250101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink Open Access Journals customDbUrl: eissn: 1869-4101 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000331383 issn: 1869-4101 databaseCode: C24 dateStart: 20100101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BixAX3o9AWQUJcQGLxM7D4bZdtqKHXUUVrRYuVuzYNBKbrbJdxM9n7DxQoKoEF0u7niTOeMb-Jra_AXiNvscKHWaEUqUIzreGyEQaUmRpXJTG8b24ZBPpcslXqyzvDoVt-93u_ZKkG6mdW_Pk_RbjpigiNv0qwpKQEUSO-3HIM7uRb9adcXDjL2Mhxl39CZkrLx3NQo6s_yqE-fdGyWG19A9mUTcbHd37v_e4D3c79OlPW3N5ADd0_RBuL7r19UewnK8vbNo0vJ-vrD00fscGdO5Xtd9-uv_gI2j056ez6fGil6rWLtsRCpmmaDlpd41-DKdH88-zT6TLuEBUzMNLolVJy4BliYpMVMiERwgXjS4pk0mg48yUMlGmDO0aWGQQOTIM4WRSKmZUFsSaPYG9elPrZ-AbQ5Ulp8cBAyNOxJmIHVOVySKiZYE_PAj7HhCqoyO3WTG-CxeW8ES0ihKoKOEUJX568Ha45qIl47hW-tB27CBpibTdH5vmm-j8UkimLGIyimt7plZyWWgciMqYmgDbrzw46M1CdN69FYi5bJoWGqQevBqq0S_tYktR682ulaGWjJB58LS1oqElCAozGjPqAR_Z16ip45q6Onfc3_iuMaLEwIN3vXX9btd1unjTmuvoER-rs6nTxm69E5Sl2FfP_-2-L-AOdZZMCY0OYA_tS7-EW-rHZbVtJnAzPTmz5Sp1JZ_A_uF8mZ9MnMdO3AcQLPP4K9bkx4v8yy-Yfjr1
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFAEX3gVDASMBF1jV3vUTCaHQpmrUJsqhrcppa693qSXiBKeB8qf4jcyuH5UB5dYDx9hjZx_fzH7j2Z0BeIW6xxLpxoRSIQiut4qkQapIEod-kimT78UUmwjH4-jkJJ6swa_mLIzeVtnYRGOos5nQ38i3cJ3TpTGoE36cfyO6apSOrjYlNCpY7MufP9BlW3wY7uD8vqZ0d3C4vUfqqgJE-JF7TqTIaOawOBCe8pI0iDykREpmlKWBI_1YZWkgVObqOI-nkB0xdFPSIBNMidjxJcP3XoN1T4O9B-uT4Wjyuf2q4zDmos_XnM6Jgq0FunueR3TVWGRTLiMXnRXQFAr4F7v9e5NmG6n9I6upWQl37_xvY3gXbtec2-5XSnIP1mRxH26M6l0FD2A8mM51sTjsti20FpR2nQPpzM4LuwpYvLeRKtuDo-3-cNRI5VNT4wmFVJlUmXiXpXwIR1fSmw3oFbNCPgZbKSp0Sn40k-hnI7tGxhyKOE08miX4wwK3mXsu6iTsuhbIV26csSjgFV444oUbvPALC962z8yrFCQrpT9pSLWSOn24uTArv_DaGvGUCc0TlYikPkmcRmki0fxmPlUOtl9YsNkAiNc2bcEv0WPBy_Y2WiMdYkoKOVtWMlSnYGQWPKrw27YEqXBMfUYtiDrI7jS1e6fIz0zGc-yrj9zYseBdowSX7Vo1Fm8qRen8xU5-3DejsZwuOWUhztWT1f19ATf3DkcH_GA43n8Kt6hRZkqotwk9xJZ8BtfF9_N8UT6v7YENp1etPr8BYmib0w
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwEB4tC1px4f0ILBAk4AJWEztPJITKthXVslUPLFrtxcSOzUaiaWm3sPw1fh1j57EKoN72wLHNpB0734y_icczAM_Q9lim_JRQKiXB9VYTEQlNsjQOs1zbei-22UQ8mSRHR-l0C341Z2FMWmXjE62jzufSvCPv4TpnWmNQL-7pOi1iOhi9XXwjpoOU2Wlt2mlUENlXP39g-LZ6Mx7gs35O6Wj4ce89qTsMEBkm_ilRMqe5x9JIBjrIRJQESI-0yikTkafCVOcikjr3zZ5PoJEpMQxZRJRLpmXqhYrh716Cy6hXatIJp-Fx-37HY8zH6K85p5NEvRUGfkFATP9Y5FU-I2edtdC2DPgXz_07XbPds_2jvqldE0fX_-fZvAHXaibu9ivTuQlbqrwFOwd1rsFtmAxnC9NCDqfAlcY2lm5dGenELUq32sZ47SKBdoeHe_3xQSNVzGznJxTSy6yqz7teqjtweCGjuQvb5bxU98HVmkpTqB-dJ0bfyLmRR8cyFVlA8ww_OOA3OOCyLs1uOoR85TZESyJeYYcjdrjFDj9z4GV7z6IqTLJR-p2BVytpiorbL-bLL7z2UVwwadijloky54tFIjKFTjkPqfZQf-nAbgMmXnu6FT9HkgNP28voo8zGU1aq-bqSoaYwI3PgXoXlVhMkyCkNGXUg6aC8o2r3Slmc2DroONYQGbPnwKvGIM712jQXLyqj6fzFoPjUt7Oxnq05ZTE-qwebx_sEdtBm-IfxZP8hXKXWrimhwS5sI7TUI7giv58Wq-Vj6xhc-HzRtvMbEpajNg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Empowering+cancer+research+in+Europe&rft.jtitle=Insights+into+imaging&rft.au=Mart%C3%AD-Bonmat%C3%AD%2C+Luis&rft.au=Blanquer%2C+Ignacio&rft.au=Tsiknakis%2C+Manolis&rft.au=Tsakou%2C+Gianna&rft.date=2025-02-24&rft.issn=1869-4101&rft.eissn=1869-4101&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs13244-025-01913-x&rft.externalDocID=oai_DiVA_org_umu_237322
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1869-4101&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1869-4101&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1869-4101&client=summon